146 related articles for article (PubMed ID: 11684727)
1. Mantle cell lymphoma presenting as a breast mass.
Windrum P; Morris TC; Catherwood MA; Alexander HD; McManus DT; Markey GM
J Clin Pathol; 2001 Nov; 54(11):883-6. PubMed ID: 11684727
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy with rituximab following high-dose therapy and autologous stem-cell transplantation for mantle cell lymphoma.
Mangel J; Buckstein R; Imrie K; Spaner D; Crump M; Tompkins K; Reis M; Perez-Ordonez B; Deodhare S; Romans R; Pennell N; Robinson JB; Hewitt K; Richardson P; Lima A; Pavlin P; Berinstein NL
Semin Oncol; 2002 Feb; 29(1 Suppl 2):56-69. PubMed ID: 11842390
[TBL] [Abstract][Full Text] [Related]
3. Mantle cell lymphoma: 2012 update on diagnosis, risk-stratification, and clinical management.
Vose JM
Am J Hematol; 2012 Jun; 87(6):604-9. PubMed ID: 22615102
[TBL] [Abstract][Full Text] [Related]
4. Real-time polymerase chain reaction estimation of bone marrow tumor burden using clonal immunoglobulin heavy chain gene and bcl-1/JH rearrangements in mantle cell lymphoma.
Andersen NS; Donovan JW; Zuckerman A; Pedersen L; Geisler C; Gribben JG
Exp Hematol; 2002 Jul; 30(7):703-10. PubMed ID: 12135667
[TBL] [Abstract][Full Text] [Related]
5. Primary gastric mantle cell lymphoma in a patient with long standing history of Crohn's disease.
Raderer M; Püspök A; Birkner T; Streubel B; Chott A
Leuk Lymphoma; 2004 Jul; 45(7):1459-62. PubMed ID: 15359648
[TBL] [Abstract][Full Text] [Related]
6. Confirmation of the mantle-cell lymphoma International Prognostic Index in randomized trials of the European Mantle-Cell Lymphoma Network.
Hoster E; Klapper W; Hermine O; Kluin-Nelemans HC; Walewski J; van Hoof A; Trneny M; Geisler CH; Di Raimondo F; Szymczyk M; Stilgenbauer S; Thieblemont C; Hallek M; Forstpointner R; Pott C; Ribrag V; Doorduijn J; Hiddemann W; Dreyling MH; Unterhalt M
J Clin Oncol; 2014 May; 32(13):1338-46. PubMed ID: 24687837
[TBL] [Abstract][Full Text] [Related]
7. [A patient with mantle cell lymphoma who successfully underwent auto-PBSCT in combination with in vivo purging of tumor cells using rituximab].
Kanaji N; Ishibashi K; Uno H; Hino N
Gan To Kagaku Ryoho; 2002 Dec; 29(13):2569-72. PubMed ID: 12506485
[TBL] [Abstract][Full Text] [Related]
8. Mantle cell lymphoma: 2013 Update on diagnosis, risk-stratification, and clinical management.
Vose JM
Am J Hematol; 2013 Dec; 88(12):1082-8. PubMed ID: 24273091
[TBL] [Abstract][Full Text] [Related]
9. Blastoid mantle cell lymphoma presenting as acute leukemia: a case report.
Dongre A; Kanchankar N; Deshmukh M; Wasnik D; Dongre T
Pan Afr Med J; 2021; 39():150. PubMed ID: 34527166
[TBL] [Abstract][Full Text] [Related]
10. [Primary breast lymphoma].
Cohen Y; Goldenberg N; Kasis S; Shpilberg D; Oren M
Harefuah; 1993 Jul; 125(1-2):24-6, 63. PubMed ID: 8225062
[TBL] [Abstract][Full Text] [Related]
11. Rituximab induces effective clearance of minimal residual disease in molecular relapses of mantle cell lymphoma.
Ladetto M; Magni M; Pagliano G; De Marco F; Drandi D; Ricca I; Astolfi M; Matteucci P; Guidetti A; Mantoan B; Bodoni CL; Zanni M; Boccadoro M; Gianni AM; Tarella C
Biol Blood Marrow Transplant; 2006 Dec; 12(12):1270-6. PubMed ID: 17162208
[TBL] [Abstract][Full Text] [Related]
12. R-CHOP or R-HyperCVAD with or without autologous stem cell transplantation for older patients with mantle cell lymphoma.
Frosch Z; Luskin MR; Landsburg DJ; Schuster SJ; Svoboda J; Loren AW; Porter DL; Stadtmauer EA; Nasta SD
Clin Lymphoma Myeloma Leuk; 2015 Feb; 15(2):92-7. PubMed ID: 25174772
[TBL] [Abstract][Full Text] [Related]
13. [Palpable mantel cell lymphoma in the breast].
Boullanger N; Renou P; Dugay J; Boyer J; de Yberlucea LR; Combe M; Coulon MA
Presse Med; 2001 Feb; 30(4):163-5. PubMed ID: 11229304
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of monocyte count at presentation in mantle cell lymphoma.
von Hohenstaufen KA; Conconi A; de Campos CP; Franceschetti S; Bertoni F; Margiotta Casaluci G; Stathis A; Ghielmini M; Stussi G; Cavalli F; Gaidano G; Zucca E
Br J Haematol; 2013 Aug; 162(4):465-73. PubMed ID: 23808798
[TBL] [Abstract][Full Text] [Related]
15. Transmission of t(11;14)-positive cells by allogeneic stem cell transplant: 10-year journey to mantle cell lymphoma.
Janikova A; Mareckova A; Baumeisterova A; Krejci M; Supikova J; Salek D; Horky O; Tichy B; Hanke I; Pospisilova S; Moulis M; Mayer J
Leuk Lymphoma; 2014 Aug; 55(8):1935-8. PubMed ID: 24160848
[No Abstract] [Full Text] [Related]
16. Minimal residual disease detection in mantle cell lymphoma: methods and significance of four-color flow cytometry compared to consensus IGH-polymerase chain reaction at initial staging and for follow-up examinations.
Böttcher S; Ritgen M; Buske S; Gesk S; Klapper W; Hoster E; Hiddemann W; Unterhalt M; Dreyling M; Siebert R; Kneba M; Pott C;
Haematologica; 2008 Apr; 93(4):551-9. PubMed ID: 18379010
[TBL] [Abstract][Full Text] [Related]
17. [Primary non-Hodgkin's lymphoma of the breast. A case report].
Villalón-López JS; Souto-Del Bosque R; Méndez-Sashida PG
Cir Cir; 2017; 85(1):70-75. PubMed ID: 26769528
[TBL] [Abstract][Full Text] [Related]
18. R-hyper-CVAD versus R-CHOP/cytarabine with high-dose therapy and autologous haematopoietic stem cell support in fit patients with mantle cell lymphoma: 20 years of single-center experience.
Widmer F; Balabanov S; Soldini D; Samaras P; Gerber B; Manz MG; Goede JS
Ann Hematol; 2018 Feb; 97(2):277-287. PubMed ID: 29147847
[TBL] [Abstract][Full Text] [Related]
19. [Therapy of mantle cell lymphoma].
Udvardy M
Orv Hetil; 2009 Dec; 150(50):2253-7. PubMed ID: 19951856
[TBL] [Abstract][Full Text] [Related]
20. Epidemiological, clinical and therapeutic profiles of mantle cell lymphoma cared for in a Moroccan center: a review of 14 cases.
Abakarim O; Mansouri A; Hebbezni A; Boujguenna I; Lahlimi FE; Tazi I
Pan Afr Med J; 2024; 47():111. PubMed ID: 38828423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]